Alzheon

Framingham, MA · Founded 2013 · Privately Held (backing)

Developer of a small molecule-based drug discovery platform designed to treat Alzheimer's disease and other neurodegenerative disorders. Alzheon is based in Framingham, MA and was founded in 2013. Its last reported valuation was $550 million in Apr 2022. It has raised $212 million across 9 recorded rounds; the latest was a $126 million later-stage round in Feb 2024.

Last reported valuation
$550.0M
Oct 2026
Priced at
—
Total raised
$212.2M
Last round
Later Stage VC
Feb 2024
What is Alzheon worth?
$550.0Mlast reported valuation · Oct 2026

Alzheon's last reported valuation, Apr 2022. Nothing priced has surfaced since.

Free account
More of Alzheon with a free account
  • ·Watch Alzheon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Alzheon funding history

9 rounds
DateRoundRaisedPost-money
Feb 2024Later Stage VC$126.3M▮
Dec 2022Seed Round$1.7M▮
Sep 2020Seed Round$2.4M▮
Apr 2019Early Stage VC$6.2M▮
May 2017Early Stage VC$19.8M▮
Feb 2016Seed Round$1.3M▮
+ 3 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Alzheon valuation

Alzheon's last reported valuation was $550 million in Apr 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Alzheon raised?

Alzheon has raised $212 million across 9 recorded rounds since 2013. The largest was a $7.3 million early-stage round in Dec 2014; the most recent was a $126 million later-stage round in Feb 2024.

Alzheon has filed 14 Form Ds with the SEC since 2013, most recently in Feb 2025 ($126 million sold to 76 investors).

How Alzheon's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Alzheon, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Alzheon

What is Alzheon worth?
Alzheon is valued at $550.0M as of Oct 2026. Alzheon's last reported valuation, Apr 2022. Nothing priced has surfaced since.
How much has Alzheon raised?
Alzheon has raised $212.2M in total funding across 9 recorded rounds.
When did Alzheon last raise?
Alzheon last raised in Feb 2024 (Later Stage VC), raising $126.3M.